海藻酸钠和壳聚糖静电复合弹性支架的制备和表征

通过静电作用和相分离技术制备海藻酸钠/壳聚糖静电复合弹性支架,研究了冷冻温度和固含量对支架材料孔径的影响及组分比对材料力学性能、亲水性、降解性能和生物相容性的影响.固含量为2%(质量分数)及冷冻温度为-24℃时,支架孔径为110~170μm,并且亲水性良好,平衡溶胀度大于1400%.改变固含量和组分比可调控材料的力学性能;循环力学测试表明,湿态支架具有良好的弹性和一定的耐疲劳性;降解速率可由组分比调控;兔脂肪干细胞(rASCs)在支架上的培养结果表明,羧基和氨基摩尔比为2∶1和1∶1时细胞以聚集体存在;羧基和氨基摩尔比为1∶2时细胞黏附于支架上,实现细胞黏附/聚集体的调控.     

纳米硅酸镁锂-壳聚糖-海藻酸钠复合支架材料的制备与性能

利用真空冷冻干燥技术, 将不同质量的纳米硅酸镁锂(nLMS)与壳聚糖(CA)和海藻酸钠(SA)混合, 制备了纳米硅酸镁锂-壳聚糖-海藻酸钠(nLMS-CS-SA)复合支架材料. 研究了不同质量分数(1%, 2%, 3%, 4%)的nLMS对nLMS-CS-SA复合支架材料的外形、 微观形貌、 溶胀率、 孔隙率、 体外降解性能和生物相容性的影响, 以确定nLMS-CS-SA复合支架材料中最佳nLMS含量. 研究结果显示, nLMS-CS-SA复合支架材料是具备形态可塑性的多孔状固体, 各组材料纵断面呈片层状, 其结构疏松且内部孔隙具有高度连通性; 随着nLMS含量的增加, nLMS-CS-SA复合支架材料的孔隙率呈现先降后升的趋势; 当nLMS的质量分数为3%时, 其溶胀比最小, 体外降解速率最慢; nLMS的添加降低了nLMS-CS-SA复合支架材料的毒性. 因此, nLMS在nLMS-CS-SA复合支架材料中的最佳含量为3%.     

氧化石墨烯-海藻酸钠-壳聚糖复合支架的制备及表征

通过冷冻干燥技术, 将不同量的氧化石墨烯与海藻酸钠和壳聚糖复合, 构建复合支架材料. 研究了不同的氧化石墨烯含量(质量分数0, 0.3%, 0.5%, 0.7%, 1%)对支架材料微观结构、 孔隙率、 溶胀比、 体外降解性能、 机械性能及生物相容性的影响, 以确定复合支架中最佳氧化石墨烯含量. 研究结果表明, 复合材料呈固态海绵状结构, 具有一定的形态可塑性; 扫描电子显微镜观察发现, 各组支架均为三维网状结构, 随着氧化石墨烯含量的增加, 孔隙尺寸逐渐降低, 孔壁厚度增加, 孔隙尺寸在140~240 μm之间; 随氧化石墨烯含量的增加, 复合支架溶胀比和体外降解速率逐渐降低, 而机械强度明显增强; 体外细胞毒性显示, 当氧化石墨烯质量分数为0.3%时, 细胞存活率最高, 而当氧化石墨烯含量增高时, 细胞活性会被明显抑制, 造成细胞死亡. 因此, 氧化石墨烯在复合支架中最佳含量为0.3%.     

羧甲基壳聚糖/有机累托石纳米复合材料及其药物缓释性能研究

利用简单的溶液插层法制备了羧甲基壳聚糖/有机累托石纳米复合材料,其中累托石(REC)用十六烷基三甲基溴化铵进行改性.用X-射线衍射(XRD)、红外光谱(FTIR)和扫描电镜(SEM)表征了该纳米复合材料的微观结构和形态,实验表明羧甲基壳聚糖插层进入了累托石层间,增大了累托石的层间距,并且累托石均匀地分布在羧甲基壳聚糖基体中.以牛血清蛋白(BSA)为药物模型,研究了纳米复合材料与海藻酸钠形成的微球的药物缓释性能.结果显示,该微球对药物的包封率及缓释性能与纯羧甲基壳聚糖微球相比都有较大改善,包封率从56%提高到86%,药物缓释时间从24 h上升到72 h.并且纳米复合材料/海藻酸钠微球的释药具有pH响应性,在pH为1.2的条件下释药慢,而在pH为7.4时释药快,可用于小肠或结肠定位缓释系统.因此,羧甲基壳聚糖/有机累托石纳米复合材料很有潜力作为药物载体.     

Na2SeO3-SA/CS微球/α-CPC基复合骨水泥的制备

结合壳聚糖（CS）和海藻酸钠（SA）的生物相容性及元素硒的生理活性功能，研究功能性磷酸钙复合骨水泥的制备及性能。Na₂SeO₃为药物模型，乳化交联法制备Na₂SeO₃-SA/CS纳米微球，沉淀-煅烧-球磨法制备α-TCP，按10.0:0.5:0.5的物质的量比将α-TCP、 DCPD、 CaCO₃粉末混均磨匀制得α-CPC，以壳聚糖和柠檬酸复合物为固化液，将载硒微球与α-CPC调和制备Na₂SeO₃-SA/CS纳米微球/α-TCP基复合骨水泥。通过IR、 DTG、 DSC、 SEM和XRD等手段表征其结构和性能，原子荧光测定硒含量。探究了球磨时间、载硒微球掺入量、固化液组分、固液比对复合骨水泥固化、强力、降解、抗溃散、缓释等性能的影响，并以MG63肉骨瘤细胞为模型进行体外抗肿瘤活性试验。结果表明：球磨时间为4 h、复合固化液中固液比为1.0:0.6（柠檬酸与壳聚糖的质量比为30:1）、载硒微球的质量分数为5%的条件下制备的Na₂SeO₃-SA/CS/α-CPC复合骨水泥，相比于纯α-CPC，其降解速率和强度增大、抗溃散能力增强、固化时间略微缩短。SEM照片表明：缓释前圆滑的Na₂SeO₃-SA/CS微球被α-CPC均相包裹，缓释后形成了完善的三维蜂窝状多孔结构，利于细胞黏附和血管组织的长入。缓释前后的IR和XRD谱图表明：微球的掺入不影响CPC水化生成组分HA，只因降解率提升导致HA的量略微增加。复合骨水泥有效避免了Na₂SeO₃的突释现象，在40 d时硒累积释放率达32.34%，保证了活性硒的长时作用功效，肉骨瘤MG63细胞增殖抑制率在7 d时达到28.46%，故Na₂SeO₃-SA/CS/α-CPC复合骨水泥具有良好的细胞生物学效应和成骨活性。本文为植骨后所需的促修复、防止肿瘤细胞复发的功能性骨水泥材料的研究奠定了必要的实验基础。     

双重载药多层海藻酸盐-壳聚糖缓释微球的制备及体外释放

采用滴注法将海藻酸钠与钙离子交联,制成负载血管内皮生长因子(VEGF)的藻酸钙核心球,利用层层自组装技术在核心球的表面依次包覆壳聚糖、海藻酸和壳聚糖,壳聚糖中负载万古霉素(VAN),形成多药载药缓控体系.采用正交实验考察海藻酸钠浓度、钙离子浓度及壳聚糖浓度对VEGF和VAN的药物包封率和载药量的影响,优化了制备工艺.采用扫描电子显微镜观察多层微球的表面、截面形貌及粒径,采用傅里叶变换红外光谱检测海藻酸盐与壳聚糖的自组装情况,分别采用酶联免疫吸附(ELISA)双抗体夹心法和紫外分光光度法检测VEGF和VAN的包封率、载药量及体外释放情况.结果表明,海藻酸钠最优浓度为0.04g/mL,氯化钙最优浓度为0.15g/mL,壳聚糖最优浓度为0.01g/mL.微球光滑圆整,均质实心,直径900~1100μm,VEGF的包封率达61.31%,VAN的包封率为3.48%.体外释放实验结果表明,VEGF缓释时间为15.5d,并出现2个释放高峰;VAN缓释时间为4.5d,释药情况平稳持续,无明显突释.双重载药多层包覆微球兼具控制感染和促进血管生成两种潜能,有望应用于组织工程骨的基础研究和临床实践.     

磁性氟尿嘧啶壳聚糖微球的制备及其释药性能

磁性氟尿嘧啶壳聚糖微球的制备及其释药性能;氟尿嘧啶;壳聚糖;磁性微球;缓释     

多巴胺改性海藻酸多孔支架的制备与性能

生物大分子海藻酸(Alg)由于其安全、无毒、可生物降解等特性而被广泛应用于组织工程领域。 受海洋贻贝蛋白结构的启发,多巴胺(DA)具有优异的粘附性能,在碱性水溶液条件下可发生氧化自聚形成聚多巴胺(PDA)。 以Alg为基体,加入PDA纳米粒子复合,并通过冷冻干燥法制备得到Alg/PDA多孔支架材料。 结果表明,Alg/PDA多孔支架材料具有较为规整的内部结构。 改变Alg质量浓度,Alg/PDA支架材料的孔径可控制在60~120 μm之间,孔隙率可控于80%~88%。 所得的支架材料具有适宜大小的孔径和孔隙率,结果表明支架材料对细胞无毒副作用。     

高压静电法制备多孔磁性壳聚糖微球

以壳聚糖(Chitosan, CS)为基质, 通过共混法引入四氧化三铁磁性颗粒, 以硅胶(Silicagel, S)为致孔剂, 在热的NaOH溶液中溶出硅胶致孔, 采用高压静电法制备磁性壳聚糖微球. 通过SEM观察了微球的结构和形貌, 并对微球结构和形貌的影响因素及其制备工艺进行了系统的研究, 结果表明, 高压静电法制备的磁性硅胶/壳聚糖微球粒径可通过微量进样器的针头大小来控制, 并且粒径分布均匀, 实验重复性及可控性好; 当以质量体积分数为5%的壳聚糖醋酸溶液(体积分数2％, mS∶mCS=4∶1), 用8号针头进样时, 制得直径约为600 μm, 孔洞分布均匀, 孔径约为50 μm的多孔磁性壳聚糖微球. 由于磁性多孔壳聚糖微球中含有大量的活性羟基和氨基, 因此显弱碱性, 对酸性物质和金属离子的吸附作用很好, 且可通过外加磁场进行有效分离. 磁性多孔壳聚糖微球在生物分离及污水中的酸性染料处理方面具有潜在的应用价值.     

Cu(Ⅱ)印迹壳聚糖交联多孔微球去除水溶液中金属离子

研究了以Cu2+为模板的壳聚糖交联多孔微球(Cu-CSCPM)对溶液中Cu2+的吸附性能,为该材料应用于去除废水、果蔬汁等有毒重金属铜离子提供理论基础。首先制备了Cu2+印迹壳聚糖交联多孔微球,并表征了微球的一些物理化学性质;其次采用静态吸附法研究了该微球对Cu2+的吸附行为。结果发现,制得的微球表面多孔,含有活性-NH2,其含水量为69.59%,树脂骨架密度为1.22g/cm3,孔度值为73.68%,交联度为82.42%。初始浓度为60mmol/L、吸附温度40℃、pH=4.0时,Cu-CSCPM对Cu2+的饱和吸附容量为1.89mmol/g。Cu-CSCPM再生5次对Cu2+仍然具有较高吸附容量。     

In vitro degradation and release behavior of porous poly(lactic acid) scaffolds containing chitosan microspheres as a carrier for BMP-2-derived synthetic peptide

To develop a novel tissue engineering scaffold with the capability of controlled releasing BMP-2-derived synthetic peptide, porous poly(lactic acid)/chitosan microspheres (PLA/CMs) composites containing different quantities of chitosan microspheres were prepared by a thermally induced phase separation method. FTIR analysis revealed that there were strong hydrogen bond interactions between the PLA and chitosan component. Introduction of less than 30% CMs (on PLA weight basis) did not remarkably affect the morphology and porosity of the PLA/CMs scaffolds. The compressive strength of the composite scaffolds increased from 0.48 to 0.66 MPa, while the compressive modulus increased from 7.29 to 8.23 MPa as the microspheres' contents increased from 0% to 50%. In vitro degradability investigation indicated that the dissolution of chitosan component was preferential than PLA matrix and the inclusion of CMs could neutralize the acidity of PLA degradation products. Compared with the rapid release from CMs, the synthetic peptide was released from PLA/CMs scaffolds in a temporally controlled manner, mainly depending on the degradation of PLA matrix. The promising microspheres based scaffold release system can be used to deliver bioactive factors for a variety of non-loaded bone regeneration and tissue engineering application.     

Fabrication and characterization of chitosan-gelatin/single-walled carbon nanotubes electrospun composite scaffolds for cartilage tissue engineering applications

Cartilage is a connective tissue with a slow healing rate due to lack in blood circulation and slow metabolism. Designing tissue engineering scaffolds modified based on its specific features can assist its natural regeneration process. In this study, the chitosan-gelatin/single-walled carbon nanotubes functionalized by COOH (SWNTs-COOH) nanocomposite scaffolds were fabricated through electrospinning. The effect of each component and different duration of cross-linking were assessed in terms of morphology, porosity, chemical structure, thermal behavior, mechanical properties, wettability, biodegradability, and in vitro cell culture study. Adding SWNTs-COOH decreased fiber diameter, water contact angle and degradation rate while increased tensile strength, hydrophilicity, stability and cell viability, due to their high intrinsic electrical conductivity, and mechanical properties and the presence of COOH functional groups in its structure. All the sample presented a porosity percentage of more than 80%, which is essential for tissue engineering scaffolds. The presence SWNTs-COOH did not have any adverse effect on cytocompatibility. The optimal cross-linking time increased the stability of the scaffolds in PBS. It can be concluded that the chitosan-gelatin/1wt% SWNTs-COOH scaffold can be appropriate for cartilage tissue engineering applications.     

低热-高压法制备PLGA多孔支架及其体外降解研究

采用低热-高压法制备了聚(dl-丙交酯／乙交酯)75／25(PLGA75／25)组织工程多孔支架。该方法避免了使用有机溶剂，支架的孔隙率在90％以上，孔径大小分布均匀。多孔支架经过酒精处理后，支架表面产生许多微小的凹陷；用藻酸钙改性处理后，支架形态保持良好。两种处理都使支架的压缩强度有所增大，亲水性增强。虽然孔隙率高的支架降解速率稍慢，但其体外降解规律基本一致：特性粘数争力学强度衰减快，而质量损失较慢，降解6周后，支架的质量损失仅为3％左右；体外降解3周后，支架的形态保持良好，可望在细胞移植争组织修复的早期发挥支撑作用。     

Porous poly(glycerol sebacate) (PGS) elastomer scaffolds for skin tissue engineering

Poly (glycerol sebacate) (PGS) elastomer scaffolds with different porosity for skin tissue engineering were fabricated via particulate leaching. The introduction of pores lowers the hydrophilicity but improves the water uptake capability of PGS. The gel content of PGS increases with the increase of salt mass ratio, but the degree of swelling goes the opposite way due to the existence of the porous structure. The degradation rate of PGS can be tailored and controlled by the porous structure, which is of great value for its applications in tissue engineering. The feasibility of these porous PGS scaffolds for skin tissue engineering was evaluated by seeding mouse dermal fibroblasts (MDFs) onto the scaffold. In vitro cell culture results indicate good attachment, proliferation and deep penetration of MDFs into porous PGS scaffolds, which confirms the excellent biocompatibility of these scaffolds.     

Preparation,Characterization, and In Vitro Biological Evaluation of PLGA/Nano-Fluorohydroxyapatite (FHA) Microsphere-Sintered Scaffolds for Biomedical Applications

In this research, the novel three-dimensional (3D) porous scaffolds made of poly(lactic-co-glycolic acid) (PLGA)/nano-fluorohydroxyapatite (FHA) composite microspheres was prepared and characterize for potential bone repair applications. We employed a microsphere sintering method to produce 3D PLGA/nano-FHA scaffolds composite microspheres. The mechanical properties, pore size, and porosity of the composite scaffolds were controlled by varying parameters, such as sintering temperature, sintering time, and PLGA/nano-FHA ratio. The experimental results showed that the PLGA/nano-FHA (4:1) scaffold sintered at 90 °C for 2 h demonstrated the highest mechanical properties and an appropriate pore structure for bone tissue engineering applications. Furthermore, MTT assay and alkaline phosphatase activity (ALP activity) results ascertained that a general trend of increasing in cell viability was seen for PLGA/nano-FHA (4:1) scaffold sintered at 90 °C for 2 h by time with compared to control group. Eventually, obtained experimental results demonstrated PLGA/nano-FHA microsphere-sintered scaffold deserve attention utilizing for bone tissue engineering.     

Collagen-based scaffolds enriched with glycosaminoglycans isolated from skin of Salmo salar fish

In this study both collagen and glycosaminoglycans were isolated from biodegradable waste. Namely collagen was isolated from rat tail tendons and glycosaminoglycans (GAGs) from fish skin. Porous materials were then obtained based on the isolated collagen with 1 or 5% addition of GAGs by freeze-drying process. The scaffolds were studied by infrared spectroscopy, mechanical testing and examined for the porosity and density. The scaffolds structure was observed by scanning electron microscope. The adhesion and proliferation of human osteosarcoma SaOS-2 cells was examined on prepared scaffolds to assess their biocompability.The results showed that the addition of glycosaminoglycans improves the properties of collagen-based scaffolds. Mechanical strength was increased by GAGs addition as well as the porosity of studied materials. Each scaffold with and without GAGs displayed porous structure with interconnected regular shaped pores. The attachment of cells was better for pure collagen scaffold, however, GAGs additive promoted the cells proliferation on the scaffold.     

Polyester scaffolds with bimodal pore size distribution for tissue engineering

This paper presents a method for the preparation of porous poly(L-lactide)/poly[(L-lactide)-co-glycolide] scaffolds for tissue engineering. Scaffolds were prepared by a mold pressing-salt leaching technique from structured microparticles. The total porosity was in the range 70-85%. The pore size distribution was bimodal. Large pores, susceptible for osteoblasts growth and proliferation had the dimensions 50-400 microm. Small pores, dedicated to the diffusion of nutrients or/and metabolites of bone forming cells, as well as the products of hydrolysis of polyesters from the walls of the scaffold, had sizes in the range 2 nm-5 microm. The scaffolds had good mechanical strength (compressive modulus equal to 41 MPa and a strength of 1.64 MPa for 74% porosity). Scaffolds were tested in vitro with human osteoblast-like cells (MG-63). It was found that the viability of cells seeded within the scaffolds obtained using the mold pressing-salt leaching technique from structured microparticles was better when compared to cells cultured in scaffolds obtained by traditional methods. After 34 d of culture, cells within the tested scaffolds were organized in a tissue-like structure. Photos of section of macro- and mesoporous PLLA/PLGA scaffold containing 50 wt.-% of PLGA microspheres after 34 d of culture. Dark spots mark MG-63 cells, white areas belong to the scaffold. The specimen was stained with haematoxylin/eosin. Bar = 100 microm.     

Porous scaffolds based on cross-linking of poly(L-glutamic acid)

Porous scaffolds based on water-soluble PLGA and CS were prepared. The pores were verified to be alveolate, uniform and continuous. The effects of freezing temperature, freeze-drying time, solid content and molecular weight of reactants on the pore structure of the scaffolds were studied. The scaffold morphology could be adjusted by changing the freezing temperature and solid content of reacting polymer. Their degradation rate can be adjusted by changing the proportion of PLGA and CS. The porosity of scaffolds was higher than 90% and the high swelling ratio showed that these scaffolds had excellent hydrophilic performance. The in vitro culture of chondrocytes indicates that the obtained PLGA/CS porous scaffolds are very promising biomaterials for tissue engineering applications.